No Data
Express News | Climb Bio To Make Upfront Cash Payment Of $9M To Mabworks Plus Certain Additional Payments Upon Achievement Of Specified Milestones
Express News | Climb Bio Enters Exclusive License Deal With Mabworks For Rights To Develop, Commercialize MIL116 (Now CLYM116) Monoclonal Antibody, In Territory Outside China
Express News | Climb Bio Inc: Preclinical Data Expected to Be Shared Later in 2025
Express News | Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the April Pathway for Iga Nephropathy
Climb Bio to Be Added to the Nasdaq Biotechnology Index
Leerink Partners Initiates Climb Bio(CLYM.US) With Buy Rating, Announces Target Price $10
151158967 : Thank you, @Jaguar8 . Your hard work is appreciated!
103687630 : I think, what do you think of ONDS? There was good news on Wednesday but it went down. Do you think there is a chance for a rebound?
Jaguar8 OP 103687630 : I didn’t choose it because it didn’t specify how much is the contract.
103687630 Jaguar8 OP : Okay, thank you for your reply
70761249 : Can VERI make a breakthrough in the short term? The recent wildfires in Southern California are really heartbreaking, causing significant disappointment in the credibility of the media and government.
View more comments...